Friess Associates’s Globus Medical GMED Stock Holding History

Friess Associates’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-140,900	Closed	-$5.79M	–	107
2017 Q4	$5.79M	Buy	+140,900	New	+$4.93M	0.48%	74

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Friess Associates's GMED Position: Q1 2018 in Review

Friess Associates sold out of Globus Medical (GMED) in Q1 2018, closing a stake of 140,900 shares — an estimated $5.79M sold.

Friess Associates first reported a position in GMED in Q4 2017 and held it in 1 quarter. The position peaked at $5.79M in Q4 2017. 279 funds tracked by Wall St. Rank hold GMED as of Q1 2018.

Friess Associates reported no remaining Globus Medical position as of Q1 2018 after selling out during the quarter.
Friess Associates sold 140,900 Globus Medical shares in Q1 2018, an estimated $5.79M.
Friess Associates first reported a position in Globus Medical in Q4 2017 and held it in 1 quarter.
Friess Associates's Globus Medical position peaked at $5.79M in Q4 2017.
279 funds tracked by Wall St. Rank held Globus Medical as of Q1 2018.

Based on Friess Associates's 13F filing for Q1 2018, filed 15 May 2018.